The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa

No abstract is available for this paper.

• Publication year

  2010

• Venue

  AIDS (London)

• Publication date

  2010-03-27

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1097/QAD.0b013e3283360976PMID 20042849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An overview on the 2008 UNAIDS Report on the 2008 UNAIDS Report on the Global AIDS Epidemic.

  2010cited by this paper
• Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda

  2009cited by this paper
• Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.

  2009cited by this paper
• Estimation of adult antiretroviral treatment coverage in South Africa.

  2009cited by this paper
• The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa

  2008cited by this paper
• Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières

  2008cited by this paper
• Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens

  2007cited by this paper
• Methods for the Economic Evaluation of Health Care Programmes.

  1987cited by this paper

• Analysis of Drug Pricing Trends of Antiretroviral Therapies in the Management HIV/AIDS

  2025cites this paper
• Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysis

  2024cites this paper
• Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics

  2024cites this paper
• Conceptualising engagement with HIV care for people on treatment: the Indicators of HIV Care and AntiRetroviral Engagement (InCARE) Framework

  2023cites this paper
• Incidence of switching to second-line antiretroviral therapy and its predictors among children on antiretroviral therapy at general hospitals, Northern Ethiopia: A survival analysis

  2023cites this paper
• Durability of Second-Line Anti-Retroviral Therapy in a Resource-Limited Setting: An 11-Year Analytical Cohort

  2022cites this paper
• Booked Appointments for HIV treatment Title: Booked Appointments System: An evaluation of the acceptability and feasibility 1 of booked appointments in a large HIV clinic in Johannesburg, South Africa

  2022cites this paper
• Durability of switched therapy after failure of WHO-recommended antiretroviral therapy regimens in a resource-limited setting

  2022cites this paper
• Systematic Review – Knowledge, Attitudes and Practices of Healthcare Workers in Reporting Adverse Drug Reactions in Sub-Saharan Africa for Pharmacovigilance

  2022cites this paper
• Prevalence of hepatotoxicity among HIV-infected patients in Ethiopia: a systematic review and meta-analysis

  2022cites this paper
• Time to Switching to Second-line Antiretroviral Therapy and Its Predictors Among HIV/AIDS Infected Children at General Hospitals, Northern Ethiopia: A Survival Analysis

  2021cites this paper
• Immunological Treatment Failure Among Adult Patients Receiving Highly Active Antiretroviral Therapy in East Africa: A Systematic Review and Meta-Analysis

  2021cites this paper
• Study protocol: Strengthening understanding of effective adherence strategies for first-line and second-line antiretroviral therapy (ART) in selected rural and urban communities in South Africa

  2021cites this paper
• Rate of Viral Re-Suppression and Retention to Care Among PLHIV on Second-Line Antiretroviral Therapy at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia: A Retrospective Cohort Study

  2021cites this paper
• HIV_A_323445 877..887

  2021cites this paper
• Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study

  2021cites this paper
• Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation.

  2021cites this paper
• The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Failure Time Definition and CD4 Count at Failure.

  2020cites this paper
• The impact of delayed switch to second-line antiretroviral therapy on mortality, depending on failure time definition and CD4 count at failure

  2019cites this paper
• HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial

  2019cites this paper
• Second-line HIV treatment failure in sub-Saharan Africa: A systematic review and meta-analysis

  2019cites this paper
• Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa

  2019cites this paper
• Usage of central nervous system medication in HIV/AIDS patients: Longitudinal analysis (2005-2015) of prevalence and prescribing pattern changes

  2019cites this paper
• A study of profile of patients failing first line NACO recommended ART

  2018cites this paper
• How should the post-2015 response to AIDS relate to the drive for universal health coverage?

  2018cites this paper
• Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa

  2018cites this paper
• Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing

  2018cites this paper
• Assessing the Efficacy of Lopinavir/Ritonavir-Based Preferred and Alternative Second-Line Regimens in HIV-Infected Patients: A Meta-Analysis of Key Evidence to Support WHO Recommendations

  2018cites this paper
• The effectiveness of international organisations in the fight against HIV/AIDS

  2018influential citation
• Cohort profile: the Right to Care Clinical HIV Cohort, South Africa

  2017cites this paper
• Changing the South African national antiretroviral therapy guidelines: The role of cost modelling

  2017cites this paper
• Barriers to Switching Patients to Second-Line Antiretroviral Treatment Among Clinicians in Tanzania

  2017cites this paper
• HIV drug resistance and related factors in patients receiving second-line combination antiretroviral therapy in rural China

  2017cites this paper
• Growing challenges for HIV programmes in Asia: clinic population trends, 2003–2013

  2017cites this paper
• Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa

  2017cites this paper
• Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation

  2017cites this paper
• Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid

  2017cites this paper
• Factors associated to first line antiretroviral therapy (ART) failure among HIV/AIDS patients at Sanglah Hospital, Bali

  2017cites this paper
• Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis

  2016cites this paper
• The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa

  2016cites this paper
• Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study

  2016cites this paper
• Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis

  2016influential citation
• Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South Africa

  2016cites this paper
• Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa

  2016cites this paper
• The Anticipated Clinical and Economic Effects of 909090 in South Africa

  2016cites this paper
• Nkhoma, Kennedy and Seymour, Jane and Arthur, Antony (2013) An educational intervention to reduce pain and improve pain management for Malawian people living with HIV/AIDS and their family carers: study protocol for a randomised controlled trial. Trials,

  2016cites this paper
• First and Second Line Highly Active Anti-Retroviral Therapy Failure in HIV Infected Nigerian Children at University of Abuja Teaching Hospital, Nigeria

  2016cites this paper
• The economics of antiretroviral therapy in South Africa: The role of budget impact modelling in changing policy

  2016cites this paper
• Pre-ART program service delivery at a PHC facility level: access and retention of patients in care in the city of Johannesburg, South Africa

  2016cites this paper
• Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa

  2016cites this paper
• Integration of HIV Financing into Health Financing Systems in Low- and Middle-Income Countries

  2015cites this paper
• First line antiretroviral treatment failure and second line treatment outcomes among HIV patients in Southern Africa

  2015cites this paper
• Second line Antiretroviral Treatment failure and predictors among adults in northwest Ethiopia

  2015cites this paper
• The Price of Nonabandonment: HIV in Resource-Limited Settings

  2015cites this paper
• The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost–Benefit Analysis

  2015cites this paper
• First and Second Line Highly Active Anti-Retroviral Therapy Failure in HIV Infected Nigerian Children at University of Abuja Teaching Hospital Gwagwalada, Nigeria

  2015cites this paper
• Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria

  2015cites this paper
• Submitted to Manufacturing & Service Operations Management manuscript MSOM The Price of Nonabandonment : HIV in Resource-Limited Settings

  2015influential citation
• The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa

  2015cites this paper
• Profile of HIV Patients on Second Line Antiretroviral Therapy: The Indian Experience

  2015cites this paper
• Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses

  2015cites this paper
• Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China

  2015cites this paper
• Kericho CLinic-Based ART Diagnostic Evaluation (CLADE): Design, Accrual, and Baseline Characteristics of a Randomized Controlled Trial Conducted in Predominately Rural, District-Level, HIV Clinics of Kenya

  2015cites this paper
• The role of side effects in shifting patients from first line to second line ART at Nthabiseng Clinic in Soweto, Johannesburg

  2014cites this paper
• Effects of pill burden on discontinuation of the initial HAART regimen in minority female patients prescribed 1 pill/day versus any other pill burden

  2014cites this paper
• Stock-outs of antiretroviral drugs and coping strategies used to prevent changes in treatment regimens in Kinondoni District, Tanzania: a cross-sectional study

  2014cites this paper
• Biomarkers for tuberculosis in the context of HIV/AIDS in Ethiopia

  2014cites this paper
• Factors associated with developing symptomatic HIV-associated sensory neuropathy

  2014cites this paper
• The Prediction of Integrase Inhibitors Efficacy in Third Line Regimen afterFirst and Second Line Antiretroviral Therapy Failure in Senegal

  2014cites this paper
• Retention in Care and Adherence to ART are Critical Elements of HIV Care Interventions

  2014cites this paper
• The Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials

  2014cites this paper
• Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries.

  2014cites this paper
• Five-Year Trends in Antiretroviral Usage and Drug Costs in HIV-Infected Children in Thailand

  2013cites this paper
• Costs of inpatient treatment for multi‐drug‐resistant tuberculosis in South Africa

  2013influential citation
• COHORT PROFILE Cohort Profile : The Themba Lethu Clinical Cohort , Johannesburg , South Africa

  2013cites this paper
• Combined antiretroviral and anti-tuberculosis drug resistance following incarceration.

  2013cites this paper
• ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics

  2013cites this paper
• COHORT PROFILE Cohort Profile : The Themba Lethu Clinical Cohort , Johannesburg , South Africa

  2013cites this paper
• Content Analysis of National Strategic Plans on HIV/AIDS and Global AIDS Response Progress Reports from Eight Southeast Asia Countries

  2013cites this paper
• An educational intervention to reduce pain and improve pain management for Malawian people living with HIV/AIDS and their family carers: study protocol for a randomised controlled trial

  2013cites this paper
• High rate of virological re-suppression among patients failing second-line antiretroviral therapy following enhanced adherence support: A model of care in Khayelitsha, South Africa

  2013cites this paper
• Retention in Care and Outpatient Costs for Children Receiving Antiretroviral Therapy in Zambia: A Retrospective Cohort Analysis

  2013cites this paper
• The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.

  2013cites this paper
• Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa.

  2013cites this paper
• Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis

  2012cites this paper
• Cost and Resource Use of Patients on Antiretroviral Therapy in the Urban and Semiurban Public Sectors of South Africa

  2012cites this paper
• The Determinants of HIV Treatment Costs in Resource Limited Settings

  2012cites this paper
• Second-Line Antiretroviral Therapy in a Workplace and Community-Based Treatment Programme in South Africa: Determinants of Virological Outcome

  2012cites this paper
• HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions

  2012cites this paper
• The State of Health Economic Research in South Africa

  2012cites this paper
• Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa

  2012cites this paper
• Outcomes Following Virological Failure and Predictors of Switching to Second-line Antiretroviral Therapy in a South African Treatment Program

  2012cites this paper
• Barriers to Retention in Care as Perceived by Persons Living with HIV in Rural Ethiopia

  2012cites this paper
• HIV-1 Genetic Diversity and Drug Resistance among Senegalese Patients in the Public Health System

  2012cites this paper
• Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis

  2012cites this paper
• Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

  2012influential citation
• What Is the Cost of Providing Outpatient HIV Counseling and Testing and Antiretroviral Therapy Services in Selected Public Health Facilities in Nigeria?

  2012cites this paper
• Viroseq HIV-1 Genotyping System v2.0 or the procedure developed by ANRS AC11 resistance

  2012cites this paper
• Molecular characterisation of selected gastrointestinal microbiota in South African HIV-positive patients during HAART

  2012cites this paper
• Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings

  2011cites this paper